Renaissance Technologies’s Universe Pharmaceuticals Inc UPC Stock Holding History

Renaissance Technologies’s Portfolio UPC Stock Details UPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-65	Closed	-$9.58K	–	3931
2024 Q3	$9.58K	Buy	+65	New	+$111K	﹤0.01%	3460
2023 Q3	–	Sell	-7	Closed	-$9K	–	4128
2023 Q2	$9K	Sell	7 -2	-22%	-$4.3K	﹤0.01%	3831
2023 Q1	$19K	Buy	9 +3	+50%	+$8.62K	﹤0.01%	3831
2022 Q4	$32K	Hold	6	–	–	﹤0.01%	3879
2022 Q3	$12K	Hold	6	–	–	﹤0.01%	3939
2022 Q2	$13K	Buy	6 +2	+50%	+$7.65K	﹤0.01%	4153
2022 Q1	$18K	Sell	4 -2	-33%	-$10.1K	﹤0.01%	4012
2021 Q4	$32K	Buy	+6	New	+$46.1K	﹤0.01%	3817

Other funds holding UPC

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies's UPC Position: Q4 2024 in Review

Renaissance Technologies sold out of Universe Pharmaceuticals Inc (UPC) in Q4 2024, closing a stake of 65 shares — an estimated $9.58K sold.

Renaissance Technologies first reported a position in UPC in Q4 2021 and held it in 8 quarters. The position peaked at $32K in Q4 2022. 3 funds tracked by Wall St. Rank hold UPC as of Q4 2024.

Renaissance Technologies reported no remaining Universe Pharmaceuticals Inc position as of Q4 2024 after selling out during the quarter.
Renaissance Technologies sold 65 Universe Pharmaceuticals Inc shares in Q4 2024, an estimated $9.58K.
Renaissance Technologies first reported a position in Universe Pharmaceuticals Inc in Q4 2021 and held it in 8 quarters.
Renaissance Technologies's Universe Pharmaceuticals Inc position peaked at $32K in Q4 2022.
3 funds tracked by Wall St. Rank held Universe Pharmaceuticals Inc as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.